血小板衍生的可溶性CD40L及其对免疫调节的影响以及在类风湿性关节炎中抗IL6R抗体治疗结果
Carlos Zamora1, Cesar Diaz-Torne2, Maria Angels Ortiz1
1Inflammatory Diseases, Institut Recerca Hospital Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Cells
|May 13, 2025
概括
来自类风湿性关节炎 (RA) 患者的血小板显示,与健康捐赠者相比,抑制T淋巴细胞激活的能力降低. 来自RA血小板的可溶性CD40L (sCD40L) 可能是治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 细胞生物学 细胞生物学
背景情况:
- 来自健康捐赠者的血小板 (PLTs) 调节T淋巴细胞的反应.
- 来自类风湿性关节炎 (RA) 患者的PLT有助于持续的全身炎症,这表明不同的免疫调节作用.
研究的目的:
- 比较从RA患者和HD的PLTs的免疫调节效应.
- 研究RA PLT对T淋巴细胞激活和细胞因子产生的影响.
主要方法:
- 使用了细胞培养,流细胞计,蛋白质组学和ELISA.
- 从HD和RA患者的PLT中分析了它们对T淋巴细胞激活和细胞因子产生的影响.
主要成果:
- 高发病PLT抑制了T淋巴细胞增殖和IFNγ/TNF产生;RAPLT显示抑制能力降低.
- 在RAPLT中,IFNγ水平增加,与T淋巴细胞增殖,疾病活性和ACPA相关.
- RA PLT显示了急性阶段反应和补充激活中的调节蛋白,具有更高的sCD40L和PDGF-BB分泌.
- 在RA患者中增加的sCD40L预测了疾病缓解和增强T淋巴细胞激活,有助于促炎性细胞因子的产生.
结论:
- RA PLT 抑制T淋巴细胞激活的能力有所降低.
- 可溶性CD40L (sCD40L) 具有作为RA中的生物标志物和治疗标的潜力.
相关概念视频
T Cell Types and Functions
689
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
689
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K


